STEMLINE THERAPEUTICS INC's ticker is STML and the CUSIP is 85858C107. A total of 80 filers reported holding STEMLINE THERAPEUTICS INC in Q3 2017. The put-call ratio across all filers is 4.30 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2019 | $545,000 | -92.5% | 42,396 | -94.4% | 1.68% | -77.0% |
| Q4 2018 | $7,248,000 | -69.9% | 762,941 | -47.4% | 7.29% | -51.4% |
| Q3 2018 | $24,098,000 | +2.0% | 1,451,700 | -1.3% | 15.01% | +78.7% |
| Q2 2018 | $23,618,000 | +24.4% | 1,471,518 | +18.5% | 8.40% | +37.3% |
| Q1 2018 | $18,992,000 | +46.8% | 1,241,293 | +49.7% | 6.12% | +41.8% |
| Q4 2017 | $12,934,000 | +115.2% | 829,090 | +53.1% | 4.31% | +86.1% |
| Q3 2017 | $6,010,000 | +420.3% | 541,462 | +331.1% | 2.32% | +398.3% |
| Q2 2017 | $1,155,000 | – | 125,595 | – | 0.46% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| VHCP Management II, LLC | 315,980 | $3,381,000 | 1.62% |
| VHCP Management, LLC | 135,420 | $1,449,000 | 1.56% |
| Eventide Asset Management | 851,400 | $9,110,000 | 0.59% |
| CARL DOMINO INC | 26,000 | $278,000 | 0.30% |
| SABBY MANAGEMENT, LLC | 357,806 | $3,829,000 | 0.22% |
| Telemetry Investments, L.L.C. | 25,016 | $268,000 | 0.15% |
| J. Goldman & Co LP | 199,886 | $2,139,000 | 0.14% |
| BAILARD, INC. | 123,785 | $1,324,000 | 0.12% |
| BOGLE INVESTMENT MANAGEMENT L P /DE/ | 94,945 | $1,015,000 | 0.07% |
| Candriam S.C.A. | 244,000 | $2,611,000 | 0.06% |